Drug Profile


Latest Information Update: 29 Apr 2016

Price : $50

At a glance

  • Originator 3M Drug Delivery Systems
  • Class
  • Mechanism of Action Toll-like receptor 7 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Skin disorders

Most Recent Events

  • 29 Apr 2016 Chemical structure information added
  • 26 Apr 2016 Phase-I clinical trials in Skin disorders in USA (Topical) prior to April 2016
  • 26 Apr 2016 852 is available for licensing as of 26 Apr 2016. http://www.3m.com/3M/en_US/drug-delivery-systems-us/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top